Trial Profile
A phase I clinical trial of ET190L1-ARTEMIS T-cells for r/r pediatric and young adult B-cell acute lymphocytic leukemia
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 25 Jul 2018
Price :
$35
*
At a glance
- Drugs ET-190 (Primary)
- Indications B-cell leukaemia
- Focus Adverse reactions
- 25 Jul 2018 New trial record
- 04 Jun 2018 According to an Eureka Therapeutics media release, this trial is expected to initiate in 2018.